These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 1180547

  • 1. Comparison of cefoxitin and cephalothin therapy of a mixed Bacteroides fragilis and Fusobacterius necrophorum infection in mice.
    Hackman AS, Wilkins TD.
    Antimicrob Agents Chemother; 1975 Aug; 8(2):224-5. PubMed ID: 1180547
    [Abstract] [Full Text] [Related]

  • 2. Penetration of cephalothin and cefoxitin into experimental infections with Bacteroides fragilis.
    O'Keefe JP, Tally FP, Barza M, Gorbach SL.
    Rev Infect Dis; 1979 Aug; 1(1):106-12. PubMed ID: 318211
    [Abstract] [Full Text] [Related]

  • 3. Comparative in vivo efficiency of cefamandole and cefoxitin against Bacteroides fragilis.
    Bergeron MG, Gauvreau L, Nguyen BM.
    Scand J Infect Dis Suppl; 1980 Aug; suppl 25():60-5. PubMed ID: 6937954
    [Abstract] [Full Text] [Related]

  • 4. [In vitro susceptibility of bacteroidaceae to cefoxitin and cephalothin (author's transl)].
    Werner H, Firsching R, Krasemann C.
    Infection; 1977 Aug; 5(1):13-6. PubMed ID: 856727
    [Abstract] [Full Text] [Related]

  • 5. beta-lactamases in bacteroides.
    Nord CE, Olsson B, Dornbusch K.
    Scand J Infect Dis Suppl; 1978 Aug; (13):27-32. PubMed ID: 28561
    [Abstract] [Full Text] [Related]

  • 6. In vivo protection of Fusobacterium necrophorum from penicillin by Bacteroides fragilis.
    Hackman AS, Wilkins TD.
    Antimicrob Agents Chemother; 1975 May; 7(5):698-703. PubMed ID: 1041218
    [Abstract] [Full Text] [Related]

  • 7. Clinical importance of cefoxitin-resistant Bacteroides fragilis isolates.
    Bieluch VM, Cuchural GJ, Snydman DR, Gorbach SL, Tally FP.
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):119-26. PubMed ID: 3652652
    [Abstract] [Full Text] [Related]

  • 8. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
    Beale AS, Gisby J.
    Infection; 1991 Jun; 19(2):101-5. PubMed ID: 2050417
    [Abstract] [Full Text] [Related]

  • 9. The use of intravenous cefoxitin sodium in patients with obstetric/gynaecologic infections.
    White JS, Gee C, Ledger WJ.
    J Antimicrob Chemother; 1978 Jul; 4(B):239-40. PubMed ID: 357395
    [No Abstract] [Full Text] [Related]

  • 10. Studies with cefuroxime and cefoxitin.
    Geddes AM, McGhie D, Ball AP, Gould I.
    Scand J Infect Dis Suppl; 1978 Jul; (13):78-81. PubMed ID: 308260
    [Abstract] [Full Text] [Related]

  • 11. Inactivation of cephalosporins by Bacteroides.
    Tally FP, O'Keefe JP, Sullivan NM, Gorbach SL.
    Antimicrob Agents Chemother; 1979 Nov; 16(5):565-71. PubMed ID: 525995
    [Abstract] [Full Text] [Related]

  • 12. [Synergistic effect of thiamphenicol and cephalothin on Bacterioides fragilis (author's transl)].
    Isono M, Aoki M, Kobayashi T, Marui T, Yamada H, Umemura A, Watanabe K, Ueno K.
    Jpn J Antibiot; 1981 May; 34(5):647-50. PubMed ID: 7026821
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of moxalactam in an animal model of subcutaneous abscesses: penetration into infected sites and in vivo activity against Bacteroides fragilis.
    Bartlett JG, Joiner KA, Dezfulian M, Marien GJ.
    Rev Infect Dis; 1982 May; 4 Suppl():S664-9. PubMed ID: 6218580
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aspects on antibacterial treatment of anaerobic infections.
    Nordbring F, Nord CE.
    Scand J Infect Dis Suppl; 1982 May; 35():59-62. PubMed ID: 6762654
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Therapy for experimental intraabdominal sepsis: comparison of four cephalosporins with clindamycin plus gentamicin.
    Louie TJ, Onderdonk AB, Gorbach SL, Bartlett JG.
    J Infect Dis; 1977 Mar; 135 Suppl():S18-22. PubMed ID: 321707
    [Abstract] [Full Text] [Related]

  • 18. In vitro susceptibility and in vivo efficacy of antimicrobials in the treatment of Bacteroides fragilis-Escherichia coli infection in mice.
    Brook I.
    J Infect Dis; 1989 Oct; 160(4):651-6. PubMed ID: 2677161
    [Abstract] [Full Text] [Related]

  • 19. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
    Brook I.
    J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.